Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
GenScript Receives FDA Emergency Use Authorization for Use of cPass(TM) SARS-CoV-2 Neutralization Antibody Test in Convalescent Plasma Screening 2021-02-11 20:30
Global Cord Blood Corporation Announces Termination of Discussion Regarding Cordlife Merger Proposal 2021-02-11 20:00
Acknowledged scientific leader and Novartis veteran joins Sai Life Sciences 2021-02-11 17:00
Ascensia Diabetes Care And Its Employees Excited To Support Spare A Rose Campaign For The Fourth Consecutive Year 2021-02-11 16:00
Firmenich Reports Solid Half Year Results despite Pandemic 2021-02-11 14:00
Zymo Research Launches COVID-19 Sequencing Service for the Detection and Surveillance of Emerging SARS-CoV-2 Variants 2021-02-11 13:46
Positivity Around Vaccine Roll-Out and Future Availability Leads to Improved Perceptions on Whole Health 2021-02-11 11:46
Transcenta Holding Announces Appointment of Dr. Michael Shi as Executive Vice President, Head of Global R&D and Chief Medical Officer 2021-02-11 08:00
First Patient Enrolled in SELUTION SLR(TM) SUCCESS PTA Study 2021-02-11 08:00
'Supercharger' to revive mainstay antibiotic in global fight against antibiotic resistance 2021-02-11 06:00
ICP DAS Biomedical Polymers Announces To Offer Taiwan High-Quality Medical TPU 2021-02-11 03:17
Care Journey Orchestration Tackles Healthcare's Biggest Operational Challenges 2021-02-11 00:02
Össur will be carbon neutral in 2021 2021-02-10 23:58
Abbott's Fast, Reliable and Convenient COVID-19 Tests Ramp Up Indonesia's Testing Capability 2021-02-10 23:14
VolitionRx Limited Announces Pricing of $20 Million Underwritten Public Offering of Common Stock 2021-02-10 22:18
RapidAI Acclaimed by Frost & Sullivan for Its AI-powered Modular Stroke Platform 2021-02-10 22:00
BioVaxys and Procare Health Announce Broad Co-Development, Joint Commercialization and Marketing Collaboration for Cancer and Viral Vaccines 2021-02-10 21:26
Elekta's ProKnow to help standardize radiotherapy for veterans 2021-02-10 21:25
I-Mab Announces China NMPA Clearance for Phase 1 Study of TJ210/MOR210 in Patients with Advanced Solid Tumors 2021-02-10 21:00
Tessa Therapeutics Announces Successful Dosing of First Patient Cohort in Phase I Allogeneic Cell Therapy Trial 2021-02-10 19:51
1 658 659 660 661 662 1619